5306-85-4 | (3R,3aR,6S,6aR)-3,6-dimethoxy-hexahydrofuro[3,2-b]furan

Packsize	Purity	Availability	Price	Discounted Price
5g	97%	in stock	$6.00	$4.00
25g	97%	in stock	$9.00	$6.00
100g	97%	in stock	$12.00	$9.00

Description

• Catalog Number: AB46334
• Chemical Name: (3R,3aR,6S,6aR)-3,6-dimethoxy-hexahydrofuro[3,2-b]furan
• CAS Number: 5306-85-4
• Molecular Formula: C8H14O4
• Molecular Weight: 174.1944
• MDL Number: MFCD00064828
• SMILES: CO[C@@]1(C)CO[C@H]2[C@@H]1OC[C@H]2O

Computed Properties

• Complexity: 143
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 4
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 4
• Rotatable Bond Count: 2
• XLogP3: -0.6

Literature

• Rheological characterization and permeation behavior of poloxamer 407-based systems containing 5-aminolevulinic acid for potential application in photodynamic therapy.

  International journal of pharmaceutics 20121101

• Formulation optimization, skin irritation, and efficacy characterization of a novel skin-lightening agent.

  Journal of cosmetic dermatology 20120601

• Characterization of a pseudo ternary phase diagram of poloxamer 407 systems for potential application of 5-aminolevulinic acid in photodynamic therapy.

  International journal of pharmaceutics 20111128

• Green synthesis of dimethyl isosorbide.

  ChemSusChem 20100525

• Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients.

  Skin pharmacology and physiology 20080101

• Stability of benzoyl peroxide in aromatic ester-containing topical formulations.

  Pharmaceutical development and technology 20070101

• Treatment of aphthous stomatitis with saturated potassium nitrate/dimethyl isosorbide.

  Quintessence international (Berlin, Germany : 1985) 20040201

• Capping carious exposed pulps with potassium nitrate, dimethyl isosorbide, polycarboxylate cement.

  Dentistry today 20030101

• Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.

  Pharmaceutical research 20020501